Strong recommendations presented for tapinarof cream, roflumilast cream, lebrikizumab, nemolizumab with ...
Systematic review and network meta-analysis included 93 trials evaluating 42 interventions ...
Differences between adalimumab and other targeted treatments mainly not significant By ...
Patients with psoriatic arthritis are less likely to begin disease-modifying antirheumatic ...
Approval granted for adults and children 12 years and older who ...
Frequent treatment alterations of off-label biologics and nonsteroidal systemic agents observed ...